Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Shoppers return gives Retail Food Group a boost despite class action brewing
    • News

    Shoppers return gives Retail Food Group a boost despite class action brewing

    “Oooh is that a free spot?” “Are these people leaving or arriving?” These are the mutterings of many a shopper as they negotiate the parking situation at their local shopping centre lately, and it’s music to the ears of retailers.  Despite COVID accelerating ecommerce and online shopping, people are still flocking to shopping centres to

    Read More
    Public
  • Sports analytics firm backs PointsBet quantitative modelling, follows $94m investment
    • News

    Sports analytics firm backs PointsBet quantitative modelling, follows $94m investment

    Despite global markets being on edge amid interest rate rises, sportsbetting company PointsBet (ASX: PBH) has strengthened its balance sheet with a $94 million investment from Sports Investments Corp (SIG Sports) which will see the bookmaker accelerate its quantitative analytics capabilities.  The $94.16 million investment comes in the form of a Private Placement to SIG

    Read More
    Public
  • The big shift in asset prices – Where to from here?
    • Opinion

    The big shift in asset prices – Where to from here?

    Investors in the past week, no doubt, would have come across a torrent of news reports on the selloff in global share markets, rising inflation & interest rates, and energy shortages on the east coast of Australia with a real possibility of ongoing blackouts. Therefore, investors can be forgiven for feeling a little anxious about

    Read More
    Public
  • Humm and Latitude call off sale despite BNPL woes as rogue Director outmuscles Board
    • News

    Humm and Latitude call off sale despite BNPL woes as rogue Director outmuscles Board

    In a remarkable series of events headed by one rogue Director, the proposed $335 million sale of Humm’s (ASX: HUM) buy-now-pay-later division to Latitude (ASX: LFS) has been shot down just two days after the Chair of Humm pleaded with shareholders to accept the acquisition proposal.  What makes the saga most incredible is the global

    Read More
    Public
  • Lumos Diagnostics partners with Apatek to create rare disorder test for newborns
    • News

    Lumos Diagnostics partners with Apatek to create rare disorder test for newborns

    Phenylketonuria. Most people won’t know what it is, let alone how to say it, let alone spell it. But for the few who do, they know it’s a serious birth defect that can have devastating effects.  Also known as PKU, phenylketonuria is a very rare, congenital disorder that causes a build up of amino acid

    Read More
    Public
  • Rex vs Qantas saga continues, will Netflix seek rights to produce?
    • News

    Rex vs Qantas saga continues, will Netflix seek rights to produce?

    Who doesn’t love a story about an underdog? Seeing the little guy triumph over the bully is the plotline of many a bildungsroman, and Netflix’s latest hit drama series ‘Rex vs Qantas’. Ok, just kidding, but we’re convinced it’s only a matter of time before someone produces the show seeing as there’s more than enough

    Read More
    Public
  • «
  • ‹
  • 367
  • 368
  • 369
  • 370
  • 371
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.